You can buy or sell Dynavax and other stocks, options, and ETFs commission-free!
Dynavax Technologies Corp. operates as a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel vaccines and immuno-oncology therapeutics. Its product includes HEPLISAV-B, which prevents infection caused by all known subtypes of hepatitis B virus in adults 18 years of age and older.
52 Week High
52 Week Low
-$0.02 per share
$0.01 per share